drugset / Trial / NCT05066373
Scintigraphy Study to Evaluate the Gastrointestinal Behavior of EDP1815 Oral Dosage Forms
Non-randomizedCrossoverOpen-labelOther
Summary
This study is to find out how different types of capsules or tablets containing EDP1815 move through the GI tract and release the drug after being swallowed. The capsules and tablets also contain a very small dose of a commonly used radioactive label called technetium-99m which is released in the GI tract to be seen on pictures taken by a scanner (gamma scintigraphy).
Timeline
- Start
- 2021-08-09
- Primary completion
- 2022-08-11
- Completion
- 2022-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EDP1815 | Other / unclassified | — | Oral |
Indications
No indication recorded.